Darryl S. Rich, Pharm.D., M.B.A., FASHP

Slides:



Advertisements
Similar presentations
Healthcare Failure Mode and Effect AnalysisSM
Advertisements

Darryl S. Rich, Pharm.D., M.B.A., FASHP
Where does Failure Mode and Effects Analysis (FMEA) come from?  Developed by the Aerospace industry in the1960s  Spread to the Automotive industry 
TIGER Standards & Interoperability Collaborative Informatics and Technology in Nursing.
FMEA By Andy Klimes. Outline What is FMEA?What is FMEA? HistoryHistory BenefitsBenefits ApplicationsApplications ProcedureProcedure Sample WorksheetSample.
Hospital Pharmacy Payam Parchamazad, PharmD Staff Pharmacist
© Copyright, The Joint Commission 2008 National Patient Safety Goals.
Lucas Phillips Anurag Nanajipuram FAILURE MODE AND EFFECT ANALYSIS.
Strategies to Reduce Medication Errors in Hospital Settings Suzanne Smith BSN, RN Critical Care Staff Nurse Community Hospital.
Error Prone Abbreviations
Failure Mode & Effect Analysis (FMEA)
Presented to: [Date] By (Insert Name) Failure Mode and Effect Analysis (FMEA)
Medication Safety Part 2
Applying DMAIC Methodology to Medication Reconciliation
by Joint Commission International (JCI)
Presented to [Date] By [Insert Name] The Application of FMEA to a Medication Reconciliation Process.
By Ruth Kavita Senior Pharmaceutical Technologist, KNH.
JCAHO UPDATE June The Bureau of Primary Health Care is continuing to encourage Community Health Centers to be JCAHO accredited. JCAHO’s new focus.
1. Infection Control Risk Assessment Terrie B. Lee, RN, MS, MPH, CIC Director, Infection Prevention & Employee Health Charleston Area Medical Center Charleston,
Quality Assessment and Performance Improvement: What’s New in QAPI for 2015! June 17, 2015 Michele Kala, MS, RN, Director of Accreditation and Certification.
Preventing Surgical Complications Prevent Harm from High Alert Medication- Anticoagulants in Primary Care Insert Date here Presenter:
Occurrence Reports. An occurrence report is a document used to record an event when it occurs Occurrences are reported each time an occurrence occurs.
Medication Use Process Part One, Lecture # 5 PHCL 498 Amar Hijazi, Majed Alameel, Mona AlMehaid.
CHAPTER 1 The Nursing Process and Drug Therapy Mosby items and derived items © 2007, 2005, 2002 by Mosby, Inc., an affiliate of Elsevier Inc.
Copyright © 2012 Wolters Kluwer Health | Lippincott Williams & Wilkins Chapter 10Safety Concerns in Healthcare.
Copyright © 2013, 2010 by Saunders, an imprint of Elsevier Inc. Chapter 2 Application of Pharmacology in Nursing Practice.
Managing Hospital Safety: Common Safety Concerns Part 1 of 4.
Occurrence Reports. An occurrence report is a document used to record an event when it occurs Occurrences are reported each time an occurrence occurs.
MEDICATION MANAGEMENT P&T COMMITTEE AND FORMULARY MANAGEMENT EMTENAN ALHARBI, Msc CLINICAL PHARMACIST.
Preventing Errors in Medicine
PROMOTING PATIENT SAFETY BY PREVENTING MEDICAL ERRORS Safety concerns facing health care systems today.
8 Medication Errors and Prevention.
Failure Modes and Effects Analysis (FMEA)
UNIVERSITY OF SAN FRANCISCO N653 INTERNSHIP: CLINICAL NURSE LEADER ANGELA HUANG Medication Transcription Error Prevention.
Effectiveness of risk management process towards error reduction in the laboratory at Sakra World Hospital AUTHORS: Dr. Shabnam Roohi Mr. Deepak Agarkhed.
SHOPS is funded by the U.S. Agency for International Development. Abt Associates leads the project in collaboration with Banyan Global Jhpiego Marie Stopes.
Assuring Compliance with the JCAHO 2004 Standards: Medication Management Patricia C. Kienle, RPh, MPA, FASHP Medication Safety Manager Cardinal Health.
March 16, 2016 CanadianClinicalDiagnostics.com ©Canadian Clinical Diagnostics.
Nongovernmental regulations
Governing Body QAPI 2013 Update for ASC
Fault Trees.
The Nursing Process and Drug Therapy
FMEA By Andy Klimes.
and what you can do to minimize their occurrence
Risk Assessment Meeting
8 Managing Risk (Premium).
Prevention of Medical Errors
FMEA.
Failure Modes and Effects Analysis (FMEA)
Quality Risk Management
Patient Safety and Quality Improvement
Medication Safety Dr. Kanar Hidayat
GE 6757 TOTAL QUALITY MANAGEMENT
Healthcare Failure Mode and Effect AnalysisSM
PROMOTING PATIENT SAFETY BY PREVENTING MEDICAL ERRORS
Medication Errors: Preventing and Responding

Special Topics in Vendor-Specific Systems
The benefits to perform FMEA
RISK REDUCTION PROCESS
QAPI Implementation: Phase 3 CMS Requirements of Participation
CREOG Patient Safety Series: Safety in Women’s Healthcare
Failure Mode and Effect Analysis
Failure Mode and Effect Analysis
Medication Safety Dr. Kanar Hidayat
8 Medication Errors and Prevention.
Chapter 20 Evaluation Evaluation is the final step of the nursing process. In this step you determine if your client’s condition or well- being has improved.
Protocol Approval Criteria
Development and implementation of a multidisciplinary fall prevention plan within an inpatient behavioral health unit Nicole Van Kampen, BSN, RN Ferris.
Presentation transcript:

Complying with the FMEA Requirements of the New Patient Safety Standards Darryl S. Rich, Pharm.D., M.B.A., FASHP Associate Director, Surveyor Development and Management Joint Commission

New Patient Safety Standards It’s a leadership thing! Manage variation in performance Integrated patient safety program implemented Ongoing proactive program to identify risks to patient safety and reducing errors Patient safety is a high priority Copyright JCAHO 2001

LD.5.2 Leaders ensure that an ongoing, proactive program for identifying risks to patient safety and reducing medical/health care errors is defined and implemented. Copyright JCAHO 2001

Requirements of LD.5.2 At least annually, select at least one high-risk process for proactive risk assessment such selection to be based, in part, on information published periodically by the Joint Commission that identifies the most frequently occurring types of sentinel events and patient safety risk factors Copyright JCAHO 2001

High Risk Processes PI.4.2 – Processes that involve risks or may result in sentinel events Medication Use Operative and other procedures Use of blood and blood components Restraint use Seclusion, when a part of care Care/services provided to high-risk populations Resuscitation Copyright JCAHO 2001

The Medication Use Process Selection, Prescribing or Preparing and Procurement, Ordering, and Dispensing and Storage Transcribing Monitoring Administration Copyright JCAHO 2001

Requirements of LD.5.2 Conduct a Failure Mode and Effects Analysis (FMEA) Assess the intended and actual implementation of the process to identify the steps in the process where there is, or may be, undesirable variation (i.e., what engineers call potential "failure modes") Copyright JCAHO 2001

Step 1 Construct a Detailed Flow Chart of the Process Multi-disciplinary participation of all those involved in the process Allocate plenty of time for this step Be as detailed and complete as possible Learn the flow chart process and symbols Flow charting software can help Copyright JCAHO 2001

Step 2 Determine each step that can “fail” and how it can “fail” Order not pulled in Timely manner Order Transcribed By Unit Clerk into MAR Physician Writes Order Medication Order Order Pulled From Chart Writing illegible Order incomplete Non-formulary drug Used felt pen Confusion abbrev. used Look-alike drug ordered Contrary to approved clinical protocol NCR copy of order sent to pharmacy Transcription error Order Transcribed By Pharm Tech Into Pharmacy System Copyright JCAHO 2001

Requirements of LD.5.2 For each identified "failure mode" identify the possible effects on patients (what engineers call the "effect"), and how serious the possible effect on the patient could be (what engineers call the "criticality" of the effect) Copyright JCAHO 2001

Step 3 Determine the “effect” of each possible “failure” Illegible handwriting Wrong drug, dose, freq, route Incomplete order Wrong dose, freq, route Non-formulary drug More expensive therapy Used felt pen Cannot be read on NCR copy Confusing abbreviation used Wrong dose Look alike drug name used Wrong drug Doesn’t followed approved clinical protocol Copyright JCAHO 2001

Step 4 Determining how serious the possible effect(s) can have on the patient – criticality For each effect: Estimate likelihood of failure (occurrence scale rank) Estimate severity of failure (severity scale rank) Estimate probability that failure is detected (detection scale rank) Then compute criticality index is product of above three or CI=OSR x SSR x DSR Copyright JCAHO 2001

Occurrence Scale Likelihood Probability Remote (1) 1 in 10,000 No known occurrence Low (2, 3, 4) 1 in 5,000 Possible, but no known data Moderate (5, 6) 1 in 200 Documented but infrequent High (7, 8) 1 in 100 Documented and frequent Very High (9, 10) 1 in 20 Documented, Almost certain Copyright JCAHO 2001

Severity Scale Outcome possibilities Slight annoyance (1) May affect the system Moderate System Problem (2, 3) May affect the patient Major System Problem (4, 5) Minor Injury (6) Major Injury (7) Terminal Injury or Death (8, 9) Copyright JCAHO 2001

Detection Scale Likelihood Probability Very High (1) 9 out of 10 Error always detected High (2, 3) 7 out of 10 Error likely to be detected Moderate (4, 5, 6) 5 out of 10 Moderate likelihood of detection Low (7, 8) 2 out of 10 Low likelihood of detection Remote (9) 0 out of 10 Detection not possible at any point Copyright JCAHO 2001

Step 4 (con’t) Rank prioritize the failure modes based on their criticality index. Copyright JCAHO 2001

Example: Top 5 criticality-indexed failure modes* Having lethal drugs available on floor stock Mistakes in math when calculating doses Doses or flow rates for IV’s calculated incorrectly Not checking armbands before administration Excessive drugs on nursing floor stock *From: E. Williams and R. Talley “The Use of Failure Mode Effects and Criticality Analysis in a Medication Error Subcommittee” Hospital Pharmacy 1994 (Apr); 29(4): 331-338 Copyright JCAHO 2001

Requirements of LD.5.2 For the most critical effects, conduct a root cause analysis to determine why the variation (the failure mode) leading to that effect may occur Copyright JCAHO 2001

Step 5 Conduct root cause analysis of top CI failure modes Equipment People Lack of MD order entry Lack of Preprinted Order Sheets Poor handwriting skills of MD MD not informed of need/P&P Illegible Handwriting No verification process No list of unapproved abbrev. Environment Process Copyright JCAHO 2001

Requirements of LD.5.2 Redesign the process and/or underlying systems to minimize the risk of that failure mode or to protect patients from the effects of that failure mode Copyright JCAHO 2001

Step 6 Brainstorm actions that could reduce the criticality index starting with failure modes that have the highest CI value that: Decrease likelihood of occurrence Decrease the severity of effects Increase the probability of detection Copyright JCAHO 2001

Requirements of LD.5.2 Pilot test and implement the redesigned process. Identify and implement measures (indicators) of the effectiveness of the redesigned process. Copyright JCAHO 2001

Requirements of LD.5.2 Implement a strategy for maintaining the effectiveness of the redesigned process over time. Copyright JCAHO 2001

Note similarities to PI PI.2 The new/modified process is designed well. PI.2.1 Performance expectations are established for new/modified processes PI.2.2 The performance of new/modified processes is measured PI.5 Improved performance is achieved and sustained over time Copyright JCAHO 2001

Remember Take small bites – keep it simple. FMEA on PCA Think: “what could possibly go wrong” Or what has gone wrong frequently in past Any modification to the process, creates new risk points. Copyright JCAHO 2001

Parting Thought On survey, JCAHO is currently not evaluating how good your FMEA process is. JCAHO is evaluating whether you used a proactive process (that includes the elements of the intent) to determine risk points and then took action to reduce the risk Copyright JCAHO 2001

Questions?